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Cryo-EM structure of the adenosine A2A
receptor coupled to an engineered
heterotrimeric G protein
Javier Garcı´a-Nafrı´a†, Yang Lee†, Xiaochen Bai‡, Byron Carpenter§,
Christopher G Tate*
MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
Abstract The adenosine A2A receptor (A2AR) is a prototypical G protein-coupled receptor
(GPCR) that couples to the heterotrimeric G protein GS. Here, we determine the structure by
electron cryo-microscopy (cryo-EM) of A2AR at pH 7.5 bound to the small molecule agonist NECA
and coupled to an engineered heterotrimeric G protein, which contains mini-GS, the bg subunits
and nanobody Nb35. Most regions of the complex have a resolution of ~3.8 A˚ or better.
Comparison with the 3.4 A˚ resolution crystal structure shows that the receptor and mini-GS are
virtually identical and that the density of the side chains and ligand are of comparable quality.
However, the cryo-EM density map also indicates regions that are flexible in comparison to the
crystal structures, which unexpectedly includes regions in the ligand binding pocket. In addition, an
interaction between intracellular loop 1 of the receptor and the b subunit of the G protein was
observed.
DOI: https://doi.org/10.7554/eLife.35946.001
Introduction
The adenosine A2A receptor (A2AR) is an archetypical Class A G-protein-coupled receptor (GPCR)
(Venkatakrishnan et al., 2013). A2AR is activated by the endogenous agonist adenosine and plays a
prominent role in cardiac function, the immune system and central nervous system, including the
release of the major excitatory neurotransmitter glutamate (Fredholm et al., 2001; Fredholm et al.,
2011). Given the widespread tissue distribution and physiological relevance of A2AR, it is a validated
drug target for many disorders (de Lera Ruiz et al., 2014), including Parkinson’s disease
(Hickey and Stacy, 2012) and cancer (Leone et al., 2015). A2AR is one of the most stable GPCRs
and structures have been determined of A2AR in an inactive state bound to inverse agonists
(Dore´ et al., 2011; Jaakola et al., 2008; Congreve et al., 2012; Hino et al., 2012; Liu et al., 2012;
Segala et al., 2016; Sun et al., 2017), an active intermediate state bound to agonists (Lebon et al.,
2015; Lebon et al., 2011; Xu et al., 2011) and the fully active state bound to an agonist and cou-
pled to an engineered G protein, mini-GS (Carpenter et al., 2016). In addition, structure-based
drug design has been applied to inactive state structures of A2AR to develop potent and subtype
specific inverse agonists with novel scaffolds (Congreve et al., 2012) and these are currently in clini-
cal trials. Comparison of the structures has led to an understanding of the molecular determinants
for an inverse agonist compared to an agonist (Lebon et al., 2011), the conformational changes
induced by agonist binding to convert the inactive state to the active intermediate state
(Lebon et al., 2012), and the role of the G protein in stabilising the fully active state
(Carpenter et al., 2016). The active state was determined by crystallizing the receptor coupled
solely to mini-GS, an engineered G protein with eight point mutations and three deletions, including
the whole of the a-helical domain (Carpenter and Tate, 2016). Although pharmacologically mini-GS
recapitulates the ability of a heterotrimeric G protein to increase the affinity of agonist binding to
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the receptor (Carpenter et al., 2016), the roles for the bg subunits could not be described. In terms
of the interactions between a heterotrimeric G protein and a Class A GPCR, the vast majority of
interactions are made by the a subunit, in particular the C-terminal a5 helix (Rasmussen et al.,
2011). However, there was an interaction between the b subunit and the b2-adrenoceptor
(Rasmussen et al., 2011) and also between the b subunit and the class B receptors for calcitonin
(Liang et al., 2017) and glucagon-like peptide (Zhang et al., 2017; Liang et al., 2018). In addition,
there is mutagenesis data suggesting that the a2-adrenergic receptor directly interacts with the b
subunit (Taylor et al., 1994; Taylor et al., 1996). We therefore determined the structure of A2AR
coupled to an engineered heterotrimeric G protein.
There are now two choices in how to determine the structure of a GPCR coupled to a heterotri-
meric G protein, which are X-ray crystallography and electron cryo-microscopy (cryo-EM). The disad-
vantage of X-ray crystallography lies in the difficulty of producing good quality crystals of a GPCR
coupled to a heterotrimeric G protein. The only successful strategy so far has been to use lipidic
cubic phase composed of the lipid MAG7:7 and to crystallise a GPCR fusion protein with T4 lyso-
zyme at the N-terminus, but there is only a single structure published to date (Rasmussen et al.,
2011). The other option is to use cryo-EM and single particle reconstruction techniques. This is now
possible given the recent developments in the field over the last few years (Fernandez-Leiro and
Scheres, 2016) together with the improved contrast provided by the recently developed Volta
phase plate (VPP) (Danev et al., 2014), which enhances the probability of getting structural data of
small proteins (Khoshouei et al., 2017). The recent structure determination of two Class B receptors
coupled to GS also shows the potential of this methodology (Liang et al., 2017; Zhang et al., 2017;
Liang et al., 2018). We thus decided to use cryo-EM to determine the structure of A2AR coupled to
an engineered heterotrimeric G protein. This would provide insights about the role of the b subunit
in coupling to A2AR, but would also provide an opportunity to directly compare the structure of the
receptor determined in the active state by X-ray crystallography and cryo-EM.
Results
Preparation of an A2AR-GS complex
In this work, we used a construct of A2AR that contained thioredoxin at the N-terminus of the recep-
tor (Nehme´ et al., 2017). This was originally designed with a rigid linker between the thioredoxin
and the receptor to generate a large hydrophilic surface to A2AR to improve crystallisation, although
this proved unsuccessful. The presence of thioredoxin did not significantly affect the pharmacology
of A2AR, as assessed by determination of its apparent KD for the inverse agonist ZM241385 or in
agonist shift assays (Figure 1). It could also be purified to homogeneity and coupled effectively to
both mini-GS (Nehme´ et al., 2017) and to the heterotrimer containing mini-GS, b1, g2 and Nb35 (Fig-
ure 1). Detergent-solubilised A2AR coupled to the heterotrimer had a molecular weight (excluding
the detergent micelle of LMNG) of approximately 135 kDa (Nehme´ et al., 2017).
The impact of the Volta Phase Plate on the cryo-EM A2AR-G-protein
complex map
Initial micrographs for the A2AR complex were collected on a FEI Titan Krios microscope using a K2
Summit detector in the absence of a Volta-potential phase plate (VPP) (Figure 2a). Data processing
showed the characteristic 2D class averages of a GPCR coupled to a heterotrimeric G protein
(Figure 2a). After 3D classification and refinement, the best model (containing 72,486 particles)
reached 6.7 A˚ resolution and showed clearly defined a-helices in both the receptor and G protein
(Figure 2a). We then collected data using the VPP on a FEI Titan Krios microscope using either a K2
Summit detector or a Falcon III detector in electron counting mode (Figure 2b and c). The K2 data-
set consisted of micrographs pooled from different days and collected with slight variations regard-
ing total dose and doses rates (see Materials and methods for details), while the Falcon III dataset
was collected in a single session over 48 hr. Both datasets were processed in an equivalent manner
to the non-VPP data, with only few minor exceptions (see Materials and methods). Since images col-
lected with a VPP possess higher contrast (Figure 2b and c), the auto-picking feature in RELION
that uses a Gaussian blob as a reference resulted in optimal particle picking without the need for
specific ‘auto-picking’ references (Fernandez-Leiro and Scheres, 2017). After 2D and 3D
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classification (see Materials and methods for details), refinement yielded models with overall resolu-
tion of 4.88 A˚ and 4.45 A˚ for the K2 Summit and Falcon III detector, respectively (Figure 2b and c).
The Falcon III model was later improved to 4.11 A˚ with further processing (see below) showing
details for most amino acid side chains after B factor sharpening. The effect of the VPP for this par-
ticular dataset was therefore essential to make ‘side-chain’ resolution accessible. A B-factor plot
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Figure 1. Pharmacological analyses of A2AR. (a) Saturation binding of the inverse agonist
3H-ZM241385 to A2AR
constructs gave the following apparent KDs: A2AR (circles), 0.5 ± 0.1 nM; TrxA-A2AR (squares), 0.8 ± 0.2 nM. (b)
Competition binding curves measuring the displacement of 3H-ZM241385 with increasing concentrations of NECA
gave the following Kis for NECA; A2AR (filled circles), 1.0 ± 0.5 mM; A2AR + mini-GS (open circles, dashed line),
2.6 ± 1.8 nM; TrxA-A2AR (filled squares), 1.1 ± 0.4 mM; TrxA-A2AR + mini-GS (open squares, dashed line), 1.8 ± 1.2
nM. Data plotted are the average from two independent experiments performed in duplicate with error bars
shown as the SD.
DOI: https://doi.org/10.7554/eLife.35946.002
The following source data is available for figure 1:
Source data 1. Raw data for A2aR competition binding curves.
DOI: https://doi.org/10.7554/eLife.35946.003
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Figure 2. Cryo-EM of the A2AR complex in the presence and absence of a VPP. (a-c) Each panel contains three
sections, with the left-hand section showing a representative micrograph obtained on a Titan Krios, the central
section depicting 2D class averages and the right-hand section the refined 3D reconstruction obtained from the
data collected. (a) Data collected without using a VPP on a K2 Summit detector. (b) Data collected using a VPP on
Figure 2 continued on next page
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(assessing the number of particles vs resolution) was used to assess the impact of the VPP
(Figure 2e). It is observed that, in the presence of the VPP, the A2AR map not only has a better reso-
lution for the same number of particles, but the B-factor improves significantly from 426 to 170
(when comparing K2 Summit with and without VPP). This becomes essential when trying to reach
high-resolution information in a reasonable time scale (especially important for high-throughput
structure determination in drug discovery). As an example, to obtain the same resolution of 4.88 A˚
using the K2 Summit detector without the VPP, one would have needed about 5 million particles,
that would require ~65 days of data collection at a Titan Krios electron microscope (in comparison to
145,169 particles collected in 48 hr with a VPP).
All cryo-EM grids were plunge-frozen from a single batch of A2AR–G protein complex and most
of the duplicate grids were made in a single freezing session. Data collection was performed at
higher magnification for the non-VPP data (magnification 200,000x and 0.66 A˚/pixel) than for the
VPP dataset (1.14 A˚/pixel and 1.07 A˚/pixel for the K2 Summit and Falcon III detectors, respectively),
positioning the high-resolution information of the non-VPP data at a better location in the detector
DQE range (Nyquist being 1.32 A˚ vs 2.14 A˚/2.28 A˚ for the non-VPP vs the VPP K2/Falcon III, respec-
tively). The VPP resolution enhancement therefore could potentially be higher if equivalent magnifi-
cations were used. Data processing was carried out as equivalent as possible for all datasets in order
to make them comparable. We therefore believe that the comparison between the VPP and non-
VPP datasets is as fair as possible, although if anything we are favouring the non-VPP data.
Comparisons of data with and without VPP had only been previously been published for samples
that readily reached high resolution without VPP. Although in our experience, the improvement is
sample dependent, these data show the potential to which the VPP can be useful in certain cases
and more comparisons will be needed in order to understand the variability in enhancement
between samples. Although we see a significant difference between the K2 and Falcon III perfor-
mance, data for the K2 with VPP was a result of merging data with different dose rates and total
doses. We therefore do not have an absolutely identical comparison of the two detectors.
Structure determination of the A2AR–GS complex
The highest resolution data set corresponded to micrographs collected on a Falcon III detector in
electron counting mode using a VPP, therefore this map was used for further processing, model
building and subsequent analysis. Data collection parameters and processing are described in the
Materials and methods section. In summary, 837 movies were collected and corrected for stage drift,
beam induced movement and dose weighting with MotionCor2 (Zheng et al., 2017). CTF fitting,
defocus and phase estimation were performed with Gctf-v0.1.06 (Zhang, 2016). Particle picking was
performed using a Gaussian blob, as implemented by RELION (Scheres, 2012). 3D classification was
performed with an ab initio model and refinement of the best classes with clear GPCR-like features
(128,002 particles) attained an overall resolution of 4.45 A˚ (using gold standard FSC of 0.143)
(Rosenthal and Henderson, 2003). Attempts to improve the model included further 3D classifica-
tion, which revealed that around 50% of the particles contained a heterogeneous g subunit. How-
ever, the resolution and quality of the overall model suffered when removing these particles, so we
therefore compromised on having poor quality density for the g subunit, but having higher resolution
for the rest of the complex.
In further attempts to improve the model, during refinement, the low-pass filter effect of the Wie-
ner filter in the regularised likelihood optimisation algorithm was relaxed through the use of a regu-
larisation parameter (T = 5). This allowed the refinement algorithm to consider higher spatial
frequencies in the alignment of the individual particles yielding a map of higher quality. Neverthe-
less, both half-reconstructions were kept completely separately, and the final resolution estimate (at
the post-processing stage in RELION) was based on the standard FSC between the two unfiltered
Figure 2 continued
a K2 Summit detector. (c) Data collected using a VPP on a Falcon III detector in electron counting (EC) mode. (d)
Gold-standard FSC curves for the three 3D reconstructions with resolutions estimated at 0.143. (e) Difference in
B-factors between the three datasets.
DOI: https://doi.org/10.7554/eLife.35946.004
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half-reconstructions. Although resolution did not improve, the quality of the map improved
noticeably.
Calculation of the local resolution in RELION showed that although the overall resolution was esti-
mated to be 4.5 A˚ the core of the complex was ~3.8 A˚ with most of the map at 4.0 A˚ resolution or
higher, with clearly visible density for the majority of amino acid side chains. As shown in Figure 3,
the regions that showed poorer resolution were the thioredoxin and the detergent micelle (a signifi-
cant fraction of the small complex), which hinders a realistic overall resolution estimation.
In order to accurately estimate the resolution of the A2AR complex map and to eliminate noise
from refinement, the detergent micelle and thioredoxin moiety needed to be excluded. Excluding
the micelle by simply tightening the mask did not yield optimal results with artefacts produced at
the interface between the model and the mask. Such a strong signal might be specific to LMNG
since, in our experience, the signal from other detergents can be masked out in this manner. We
a b
c d
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Figure 3. Local resolution cryo-EM map. (a) Local resolution map of the Falcon III + VPP model prior to refinement with signal subtracted particles as
calculated with RELION. (b) Local resolution of the same model after refinement of signal subtracted particles (also calculated with RELION) (c) A2AR
complex displayed as putty cartoons, where B-factor of the coordinates relates to the thickness of the tube. (d) Fourier shell correlation of the refined
model versus the map.
DOI: https://doi.org/10.7554/eLife.35946.005
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then decided to perform a double signal subtraction protocol where initial coordinates were used to
create a tight mask around the protein component excluding thioredoxin (A2AR, mini-GS, b, g,
Nb35), which was then subtracted from the original particles. The resulting particles were used to
produce an accurate map of the micelle and thioredoxin, which was then used to perform signal sub-
traction of the original particles, leaving them devoid of micelle or thioredoxin. Refinement of these
particles yielded an improved map at 4.11 A˚ resolution. However, it appeared that the refinement
process focused primarily on the intracellular G protein heterotrimer complex leaving a lower quality
map at the receptor region. In order to circumvent this problem, we performed refinement with the
original particles and then exchanging them for their signal subtracted equivalent (without micelle
and thioredoxin) only in the last iteration of refinement. This resulted in the best overall map at 4.11
A˚ resolution with quality density throughout (Table 1).
Attempts to remove particles with low phase shift and poor contrast (~22,000 particles
with <0.25p) decreased resolution and map quality. We therefore kept low phase shift data in the
final model.
Overall structure of the NECA-bound A2AR mini heterotrimeric G
protein complex
The A2AR cryo-EM complex structure provides insights into its structure in solution, in the absence
of crystal contacts and at more physiological conditions (pH 7.5) than the X-ray structure (pH 5.7 or
below for inactive structures). The density map of the A2AR–G protein heterotrimer displayed a local
resolution varying from 3.3 A˚ to 6.4 A˚ (Figure 3). Side chain densities were observed for most amino
acid residues (Figure 4), which were of similar quality to those in the X-ray crystallographic map of
the A2AR–mini-GS structure (Figure 5). The lowest resolution was found at the C-terminus of the b
subunit and most of the g subunit, which had very poor density. Signal subtraction and 3D classifica-
tion protocols have been used to isolate different protein conformations of small regions (Bai et al.,
2015). Upon implementation of these strategies, we did not find any other discrete conformations
of the heterotrimeric G protein, suggesting that the C-terminus of the b subunit and most of the
g subunit region are flexible. Within the cryo-EM structure of A2AR, there are two regions that lack
density and are therefore also probably disordered and flexible, namely the N-terminal section of
ECL2 (G147 to Q163) and the whole of ICL3 (E212 to S223). These regions are ordered in some crys-
tal structures, but this usually correlates with these regions forming lattice contacts. Sections of the
cryo-EM density map for which there is poor quality density and high B-factors of the refined coordi-
nates include TM1, helix 8, the second section of ECL2 that contributes relevant residues for ligand
binding (see below), ECL1 and ECL3 (Figures 3 and 4).
The overall architecture of the A2AR–heterotrimeric G protein complex is similar to the heterotri-
meric GS-coupled complexes for the b2-adrenergic receptor (Rasmussen et al., 2011), GLP1
(Zhang et al., 2017, Liang et al., 2018) and the calcitonin receptor (Liang et al., 2017). The recep-
tor and mini-Gs portions of the A2AR–G protein complex are very similar to the crystal structure of
the A2AR–mini-GS complex, with the RMSD of Ca atoms for the receptor and mini-GS components
being 0.5 A˚ and 0.6 A˚, respectively. The largest differences are found at the interface between mini-
GS and the b subunit, which have a different conformation when bg is bound. This may contribute to
a minor difference in curvature of the a5 helix in mini-GS when it is in the heterotrimer complex com-
pared to when it is bound to the receptor alone (Figure 5). However, this does not have any major
impact on the interface between the receptor and mini-GS, thus further validating the use of mini G
proteins as a surrogate for G protein heterotrimers (Carpenter et al., 2016; Carpenter and Tate,
2016; Nehme´ et al., 2017).
Cryo-EM map at the ligand binding pocket
The A2AR orthosteric binding pocket is described by two crystal structures of A2AR bound to NECA,
with one structure of A2AR in an active intermediate conformation (PDB code 2ydv) (Lebon et al.,
2011) and the other structure in the active state coupled to mini-GS (PDB code 5g53)
(Carpenter et al., 2016). The extracellular half of A2AR does not undergo any major structural
changes in the transition from the active intermediate to the mini-GS coupled active state, with the
volume of the binding pocket remaining constant and the interactions to NECA being identical
(Carpenter et al., 2016). The orthosteric binding site in the cryo-EM map has well-defined density,
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although the map has lower resolution towards the extracellular surface. The density for NECA is of
sufficient quality to allow an unambiguous orientation of NECA and the same interactions to the
receptor are observed as present in the crystal structures (Figures 5 and 6).
Despite the similarities between the orthosteric binding site observed in the cryo-EM and X-ray
structures, small differences were found in ECL2 that forms part of the binding pocket. The C-termi-
nal half of ECL2 in the X-ray structures forms a helical turn that caps the pocket and contributes side
chains that interact with NECA (Phe168 and Glu169). In the cryo-EM structure this region is more dis-
ordered. As a consequence, there is no significant side chain density for Phe168 and Glu169 in the
cryo-EM map. The fact that there is clear density for NECA and His264 excludes the possibility that
the whole of this region has poor resolution that is the extracellular portion of the receptor is not
moving as a rigid body. This is consistent with ECL2 being dynamic.
Table 1. Data collection and refinement statistics
Data collection
Microscope FEI titan krios FEI titan krios FEI titan krios
Detector Falcon III + VPP K2 Summit + VPP K2 Summit
Pixel size (A˚) 1.07 1.14 0.66
Voltage (kV) 300 300 300
Total electron dose (e-/A˚2) 30 40/40/30 50
Micrographs collected 827 906 2800
Number of frames 75 40/23/30 40
Exposure time (s) 60 10/4.6/6.5 10
Electron dose per frame (e-/A˚2) 0.4 1/1.7/1 1.25
Dose rate (e-/pixel/s) 0.5 5.2/9/6 2
Frame exposure (s) 0.8 0.25/0.115/0.216 0.25
Total number of particles
(after 2D classification)
232,739 313,879 166,313
cryo-EM 3D Refinement
Resolution (A˚) 4.11 4.88 6.71
Map sharpening B-factor (A˚2)  130  150  529
Fourier shell correlation criterion 0.143 0.143 0.143
Particles used in final 3D refinement 128,002 145,169 72,487
Defocus (mm)  0.2 to  1  0.3 to  1.2  1.2 to  3.5
Coordinate Refinement and Validation
R.m.s. deviations
Bonds (A˚) 0.07
Angles (˚) 0.984
Ramachandran Favoured (%) 94.6
Ramachandran Allowed (%) 4.89
Ramachandran Outliers (%) 0.51
Molprobity score 1.36
Clashcore, all atoms 0.79
Favoured rotamers 91.12
EMRinger score 1.93
FSC (model vs map - 0.5 cut-off) (A˚) 4.08
PDB and map deposition
PDB ID 6GDG
EMDB ID 4390
DOI: https://doi.org/10.7554/eLife.35946.006
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A second difference between the NECA-bound X-ray structures and the cryo-EM structure is a
likely absence of an interaction between Glu169 and His264. This ionic bridge affects small molecule
binding kinetics (Segala et al., 2016) and in most of the crystal structures caps the binding pocket.
Although the cryo-EM map in the region is poorer than in the rest of the molecule, it suggests a
rotamer for the imidazole group of His264 that points away from the orthosteric binding pocket (Fig-
ure 6). This might be a consequence of the pH in which the respective structures were determined.
7   AVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITI  66 
67  STGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIA  126 
127 ICWVLSFAIGLTPMLGWNNC VACLFEDVVPMNYMVYFNFFACV  186 
187 LVPLLLMLGVYLRIFLAARRQLKQM TLQKEVHAAKSLAIIVGLFALCW  246 
247 LPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTF   306 
307 
GQPKEGKAHSQGCGEGQ
ESQPLPGERARS
RKIIRSH
VLRQQEPFKA  316 
a
b
Figure 4. Modelling quality of the A2AR structure. (a) Amino acid sequence of A2AR used in the cryo-EM structure determination. Residues are
coloured according to how they have been modelled: black, good density allows the side chain to be modelled; red, limited density for the side chain
present and therefore the side chain has been truncated to Cb; blue, no density observed and therefore the residue was not modelled. Regions
highlighted in grey represent the transmembrane a-helices and amphipathic helix eight is highlighted in yellow. Cys residues involved in the formation
of disulphide bonds are in bold. In the cryo-EM structure densities for the disulphide bonds Cys74-Cys146 and Cys77-Cys166 are observed. Densities
corresponding to the disulphide bonds Cys71-Cys159 and Cys259-Cys262 are not observed in the cryo-EM data. The sequence of A2AR is from residue
8–316, with the initial Ala residue at position seven being part of the linker between the N-terminal thioredoxin fusion and A2AR. (b) Model of A2AR
showing the Ca positions of amino acid residues with poor density (spheres) and regions unmodelled (dotted lines).
DOI: https://doi.org/10.7554/eLife.35946.007
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The pKa of the histidine side chain is ~6 and most crystal structures have been obtained at lower pH
(~pH 5), favouring protonation of His264 and the formation of the ionic bridge. At a more physiolog-
ical pH of 7.5 that was used for the cryo-EM structure, His264 would be predominantly deproto-
nated and unable to form the ionic bridge. Although the rotamer for Glu169 cannot be assigned in
the cryo-EM map, His264 adopts a similar rotamer as seen in crystal structures obtained at higher
pH, such as the complexes with caffeine, XAC and ZM241385 (~pH 8), all showing a broken ionic
bridge. Therefore, it is likely that in the physiological state (represented by the cryo-EM map) this
ionic bridge is also absent, unless the surrounding pH is momentarily lowered for specific functions
(e.g. the release of high concentrations of glutamate in glutamatergic synapses).
Comparison of the G-protein–receptor interface between the crystal
and cryo-EM structures
The interface between mini-GS in the heterotrimeric G protein and A2AR in the cryo-EM structure is
very similar to the interface between mini-GS and A2AR in the X-ray structure (PDB code 5g53). The
interface in the cryo-EM structure has a buried surface of 1135 A˚2 compared to 1048 A˚2 for the
X-ray structure 5g53; the slight increase is due to interactions between ICL1 of A2AR (residues
Leu110 and Asn113) and the N-terminal helix of mini-GS (residues His41 and Arg38). The near full
length N-terminal helix was present in the mini-GS construct in the cryo-EM structure, because this is
required for the stable interaction between the a subunit and the bg subunits, whereas it was trun-
cated and disordered in the X-ray structure. The main interactions between A2AR and mini-GS in
both the cryo-EM and X-ray structures are made predominantly by the C-terminal a5 helix in mini-GS
and amino acid residues in H3, H5, H6, H7, H8 and ICL2 of A2AR (Carpenter et al., 2016). The amino
acid residues that make these interactions are identical, but the rotamers sometimes differ between
the cryo-EM and X-ray structures. This may be a reflection of the different chemical environments in
Crystal map Cryo-EM map
H387 H387
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Figure 5. Comparison of map densities from the cryo-EM data and X-ray diffraction data. The structure of the A2AR–heterotrimeric G protein complex
determined by cryo-EM is depicted as a cartoon. The four panels show regions of the structure and the associated density maps from the cryo-EM data
and, where present, electron density (2Fo-Fc) from the X-ray structure of the A2AR–mini-GS (PDB code 5g53). Densities for the maps shown in the panels
were sharpened using the following B factors (resolution of filtering in parentheses): b subunit and A2AR,  170 A˚
2 (3.7 A˚); mini-GS–A2AR interface,  130
A˚2 (3.7 A˚); NECA,  130 A˚2 (4.1 A˚).
DOI: https://doi.org/10.7554/eLife.35946.008
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which the structures were determined or the slight difference in curvature of the a5 helix in mini-GS.
In addition, some interactions may be transient and are captured in one structure and not another.
For example, Arg291 at the intracellular end of H7 of A2AR adopts a different conformation in the
cryo-EM structure compared to the crystal structure. This results in the absence of interactions
between the Arg291 side chain and mini-GS, although the backbone carbonyl can still makes poten-
tial interactions with Glu392 and the adjacent residues in H8 are still sufficiently close to mini-GS to
make interactions. This region is also the main difference to the b2AR-GS complex where the a5 helix
in GS does not interact with H7 and H8 of the receptor (Rasmussen et al., 2011).
The major difference between the structure determined by cryo-EM of the A2AR-heterotrimeric G
protein complex and the X-ray structure of the A2AR-mini-GS complex was the presence of the bg
subunit in the cryo-EM structure. No interactions were observed between A2AR and the g subunit,
but potential interactions were observed between ICL1 (residues Ser35, Asn36 and Gln38) of A2AR
and the b subunit (Arg52, Asp312, Asp333 and Phe335). This interface between A2AR and the b sub-
unit is considerably more extensive than that observed in the b2AR complex (Figure 7), where inter-
actions occur exclusively at Asp312. However, ICL1 shows higher B-factors than the rest of the A2AR
cryo-EM structure, which may suggest that the interaction is fairly weak. The recently reported cryo-
EM structures of the Class B Calcitonin receptor (Liang et al., 2017) and Glucagon-like peptide-1
receptor (Zhang et al., 2017; Liang et al., 2018) bound to heterotrimerc GS also show a similar
interaction between ICL1 and the b subunit where only Asp312 in the b subunit apparently interacts
with ICL1 of the receptor. Therefore, the larger interface between the b subunit and A2AR appears
at the moment unique to this receptor, although the physiological implications are unclear.
Mini-Gs
A2AR
βγ
Nb35
H264
F168
E169
NECA
F335
R52
D333
D312
N36
S35
Q38
a
b c
d
Figure 6. Structure of A2AR–heterotrimeric GS. (a) Superposition of A2AR (pale green) coupled to mini-Gs (pale blue) with A2AR (dark green) coupled to
mini-GS (dark blue), bg (red) and Nb35 (yellow). (b) Superposition of NECA bound to A2AR in the cryo-EM and X-ray structures after alignment of A2AR
(PyMol). (c) The position of His264 in the cryo-EM structure (dark green, density shown by black mesh), differs from its position in the X-ray structure
(light green). No density is observed for the side chain of Glu169 in the cryo-EM structure, but when modelled it would be too far away to make a
contact with His264. (d) The interface between ICL1 of A2AR (dark green) and the b subunit (red) is depicted, with density shown as a black mesh.
DOI: https://doi.org/10.7554/eLife.35946.009
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Discussion
The structure determination of A2AR in complex
with mini-GS, b, g and Nb35 at a physiologically
relevant pH has highlighted a number of differen-
ces to the structure determined by X-ray crystal-
lography of A2AR coupled to mini-GS
(Carpenter et al., 2016). Firstly, contacts
between A2AR and the heterotrimeric G protein
were identified between ICL1 and the b subunit,
and between ICL2 and part of the N-terminal a-
helix of the a subunit; these regions of the G pro-
tein were either absent or disordered, respec-
tively, in the crystal structure. Secondly, the
difference in pH under which the cryo-EM struc-
ture was determined (pH 7.5) compared to many
X-ray structures (pH <6) led to ECL2 being more
dynamic, as the potential salt bridge between
His264 and Glu169 was absent, and consequently
Phe168 was disordered. The implications of these
observations are discussed more below.
There are now two Class A receptors whose
structures have been determined coupled to het-
erotrimeric GS, b2AR (Rasmussen et al., 2011)
and A2AR, and after this work was completed,
two Class B structures coupled to GS were also
published (Liang et al., 2017; Zhang et al.,
2017; Liang et al., 2018). As expected the over-
all architecture of the receptors coupled to GS
are conserved, but the details differ. The biggest
difference between coupling of Class A receptors
to Class B receptors is that the position of H8 in
the Class B receptors is angled towards the G
protein by ~30˚compared to the Class A recep-
tors. This results in extensive contacts between
H8 and the G protein b subunit that are absent in
Class A receptors. All the receptor structures
coupled to GS show the majority of the contacts
between the a5 helix of the a subunit and H3, H5
and H6 of the receptor, with receptor-dependent
contacts in H2, H7 and H8. The differences may
arise partially from the subtle difference in bend-
ing of the C-terminal part of the a5 helix and the
different positions of the a5 helix within the
receptor, both presumably arising from the differ-
ent amino acid sequences of the respective
receptors. The interactions observed here
between A2AR and the b subunit are also
observed in the Class B receptors, but are absent
from the crystal structure of the b2AR-GS structure, although a shift of the b subunit by only a few
a˚ngstroms would be sufficient for interactions to occur.
The poor density of ECL2 in the cryo-EM map of A2AR coupled to the heterotrimeric G protein,
suggests that this region is more dynamic than suggested from the X-ray structures, maybe due to a
pH effect that breaks the salt bridge between His264 and Glu169. This salt bridge has been sug-
gested to be highly important in modulating the kinetics of ligand binding (Segala et al., 2016).
Interestingly, a recent structure (Sun et al., 2017) of A2AR bound to compound-1 was crystallised at
H5
H6
H4
α5
HN
H8
H1
H2
S35
Q38N36
D312
D333 F335
R52
HN
a
b
Figure 7. Comparison of A2AR and b2AR coupled to
heterotrimeric GS. (a) A2AR (dark green) and b2AR (dark
grey) were aligned using regions of the receptors
predicted to be within the cytoplasmic leaflet of the
lipid bilayer. The position of mini-GS (pale green)
coupled to A2AR is compared to the position of the
GTPase domain of the a subunit (pale grey) coupled to
b2AR. The bg subunits and Nb35 have been omitted for
clarity. (b) Transmembrane region H1 and ECL1 in A2AR
(dark green) extends closer to the b subunit (pale
green), whereas b2AR (dark grey) is too far away from
the b subunit (pale grey) to make extensive contacts.
DOI: https://doi.org/10.7554/eLife.35946.010
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pH 6.5, and no crystal contacts were formed by ECL2. In this structure, the N-terminal section of
ECL2 lacked density as we observed in the cryo-EM map and, in the latter region, Phe168 adopts
two conformations. In one conformation, Phe168 stacks against the ligand and in the other confor-
mation Phe168 points towards the extracellular surface (Figure 6). The ionic bridge between Glu169
and His264 seems to be present in this structure, so the two conformations of Phe168 may be a con-
sequence of the ligand. The cryo-EM structure thus adds support to the contention that ECL2 is flex-
ible and may be important in modulating the accessibility of the orthosteric binding site to ligands.
The cryo-EM structure presented here allows for the first time a direct comparison of the struc-
ture of a GPCR bound to an identical ligand in the same conformation as determined by cryo-EM
and X-ray crystallography. This is highly interesting with respect to drug discovery where tractability
and speed of the structure determination are balanced by the resolution required for a particular
aspect of any given project. Cryo-EM offers a relatively fast route to the structure of a GPCR in an
active conformation coupled to the heterotrimeric G protein GS. The quality of most of the cryo-EM
map was very similar to the electron density map from the X-ray structure, despite the reported res-
olutions being 4.1 A˚ and 3.4 A˚, respectively. This highlights the importance of the local resolution vs
the global resolution in cryo-EM maps. In both cases, the ligand density was unambiguous, but
adenosine is an asymmetric molecule and difficulties would have been encountered if the ligand was
more symmetrical, such as caffeine. However, there is no doubt that cryo-EM is preferred in terms of
overall speed; extensive protein engineering is required to obtain crystals of GPCRs (Tate and
Schertler, 2009), through adding fusion proteins, deletions of flexible regions, removal of post-
translational modifications and thermostabilisation. In theory, none of these modifications will be
required for a cryo-EM structure, particularly as mild detergents, amphipols and nanodiscs are all
compatible with structure determination of membrane proteins by cryo-EM and will maintain often
quite unstable membrane proteins in a functional state (Tate, 2010). However, once a crystal struc-
ture has been determined, they can often attain much higher resolution than structures of membrane
proteins obtained so far, although high-resolution cryo-EM structures are possible from single mole-
cule imaging (Bartesaghi et al., 2015). Another current advantage of X-ray crystallography is the
possibility of soaking crystals to get multiple structures of a receptor bound to different ligands
through molecular replacement (Rucktooa et al., 2018). Finally, there is still a size limitation of the
molecule imaged by cryo-EM for structure determination (Henderson, 1995) and experimentally this
is now at about 65 kDa (Khoshouei et al., 2017). However, given the continued drive towards
improving the technology of cryo-EM, there is no doubt that this technique will play a pivotal role in
structure-based drug design in future years (Vinothkumar and Henderson, 2016).
Materials and methods
Expression and purification of the human adenosine A2A receptor
Construction of the thioredoxin-A2AR fusion protein and C-terminally truncated A2AR (1-317), both
containing the N154A mutation, is described elsewhere (Nehme´ et al., 2017). The constructs were
expressed using the baculovirus expression system as described previously (Carpenter et al., 2016;
Carpenter and Tate, 2017a). Cells were harvested by centrifugation 72 hr post-infection, resus-
pended in hypotonic buffer (20 mM HEPES pH 7.5, 1 mM EDTA, 1 mM PMSF, cOmplete (Roche)
protease inhibitor cocktail), flash-frozen in liquid nitrogen and stored at –80˚C until use. The purifica-
tion of the thioredoxin-A2AR fusion protein was performed in the detergent LMNG in the presence
of 100 mM NECA using Ni2+-affinity chromatography followed by SEC as described previously
(Carpenter et al., 2016; Carpenter and Tate, 2017a).
Preparation of mini-Gs heterotrimer
The mini-GS construct (399) used in single particle cryo-EM reconstructions is based on the construct
393 that was used in the structure determination of the A2AR- mini-GS crystal structure
(Carpenter et al., 2016; Carpenter and Tate, 2016). However, unlike construct 393, mini-GS399
binds bg (Nehme´ et al., 2017). The expression and purification of the respective components and
assembly to make the complex containing mini-GS-b1g2, and the preparation of nanobody Nb35,
were all performed following the protocols described previously (Carpenter and Tate, 2016;
Rasmussen et al., 2011; Carpenter and Tate, 2017b).
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Preparation of the A2AR-mini-GSb1g2-Nb35 complex
Thioredoxin-A2AR, mini-GS-b1g2 and Nb35 were mixed in a molar ratio of 1:2:4, to yield a final thiore-
doxin-A2AR concentration of 1 mg/ml. 0.1 U of apyrase was added and the mixture was incubated
overnight at 4˚C. Excess G protein and nanobody were removed by SEC on a Superdex 200 Increase
column (running buffer 20 mM HEPES pH 7.5, 100 mM NaCl, 0.1% LMNG, 100 mM NECA). Peak
fractions with an absorbance value at 280 nm of 1.5–2 were used immediately for grid preparation
or flash frozen in liquid nitrogen and stored at –80˚C until use.
Radioligand binding assays
Insect cells expressing A2AR were resuspended in 1 ml of assay buffer (25 mM HEPES pH 7.5, 100
mM KCl, 1 mM MgCl2, protease inhibitor cocktail) at a final concentration of 3  10
6 cells/ml. Cells
were sheared by 10 passages through a bent 26G syringe needle. Cell membranes were diluted 50-
fold to 100-fold in assay buffer and aliquots prepared as appropriate. In saturation binding assays,
cell membranes containing A2AR were incubated with
3H-ZM241385 (0.1–40 nM) for 2 hr at 21˚C.
Non-specific binding was determined in the presence of 10 mM unlabelled ZM241385. In competi-
tion binding assays, cell membranes were incubated with NECA (1 nM - 1 mM) for 2 hr at 21˚C, in
the presence or absence of 25 mM mini-GS393. 5 nM
3H-ZM241385 was added followed by a 2 hr
incubation. Assays were terminated by filtering through PEI-treated 96-well glass fibre GF/B filter
plates (Merck Millipore, Ireland) and washing with ice-cold assay buffer. Filters were dried, placed
into scintillation vials and incubated overnight in 4 ml Ultima Gold scintillant (Perkin Elmer). Radioac-
tivity was quantified by scintillation counting using a Tri-Carb counter (Perkin Elmer). Apparent KD
and apparent Ki values were determined using GraphPad Prism version 6.0 (GraphPad Software, San
Diego, CA).
Cryo-EM grid preparation and data collection
Cryo-EM grids were prepared by applying 3 ml of sample (total protein concentration 1 mg/ml) on
glow discharged holey gold grids (Quantifoil Au 1.2/1.3 300 mesh). Excess sample was removed by
blotting with filter paper for 4–5 s prior to plunge-freezing in liquid ethane using a FEI Vitrobot Mark
IV at 100% humidity and 4˚C. In all cases, data was collected on a FEI Titan Krios microscope at
300kV. Data without VPP and initial VPP images were acquired using a Gatan K2-Summit detector
and a GIF-quantum energy filter (Gatan) with a 20 eV slit and zero loss mode to remove inelastic
scattering. For the initial non-VPP dataset, EPU automatic data collection software (FEI) was used
while the VPP date set of the K2-summit detector was collected using SerialEM automatic data col-
lection software (Mastronarde, 2005).
The non-VPP data set contained a total of 2800 micrographs, collected as 40 movie frames at a
dose rate of 2 e-/pixel/sec (1.25 e-/A˚2 per frame) for 10 s, with a total accumulated dose of 50 e-/A˚2.
The magnification was 200,000x yielding 0.66 A˚/pixel at the specimen level.
The K2-VPP dataset was the result of merging three datasets with slightly different collection
parameters: (a) 213 micrographs collected as 40 movie frames at 5.2 e-/pixel/s over 10 s for a total
dose of 40 e-/A˚2; (b) 232 micrographs collected as 23 frames at 9 e-/pixel/s over 4.6 s for a total
accumulated dose of 30 e-/A˚2; (c) 461 micrographs collected as 30 movie frames at a dose rate of 6
e-/pixel/s over 6.5 s for a total dose of 30 e-/A˚2. In all cases the magnification was set to obtain a
pixel size of 1.14 A˚.
One data set was acquired using a Falcon III detector in electron counting mode by recording 75
movie frames (0.8 s per frame) at a dose rate of 0.5 e-/pixel/s (0.4 e-/A˚2 per frame) for a total accu-
mulated dose of 30 e-/A˚2 acquired over a period of 60 s. Pixel size at the specimen was calibrated
to be 1.07 A˚. A total of 827 images were incorporated into the dataset.
Data processing and model building
All data processing were performed using RELION-2 (Kimanius et al., 2016). Good quality images
were selected manually and drift correction, beam induced motion and dose weighting was per-
formed for each of the datasets with MotionCor2 (Zheng et al., 2017), using 5  5 patches and the
corresponding dose per frame. CTF fitting and phase shift estimation were performed using Gctf-
v0.1.06 (Zhang, 2016). In all cases, auto-picking (Scheres, 2015) was performed with a Gaussian
blob as a template (Fernandez-Leiro and Scheres, 2017). Elimination of false positives or ‘bad
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particles’ was performed over two rounds of reference-free 2D classification. 10,000 random par-
ticles were used for ab initio model generation using the Stochastic Deepest Descent (SDG) algo-
rithm incorporated in RELION-2.1. The resulting model was used as input for the initial 3D
classification. After a single round of 3D classification, particles in quality models were pooled
together for refinement. The Falcon III-VPP data was divided into three classes, where two of them
presented clear structural features resembling a GPCR-G-protein heterotrimer complex. During
refinement of the Falcon III + VPP data, the low-pass filter effect of the Wiener filter in the regular-
ised likelihood optimisation algorithm was relaxed through the use of a regularisation parameter
(T = 5). This allowed the refinement algorithm to consider higher spatial frequencies in the alignment
of the individual particles yielding a map of higher quality. Nevertheless, both half-reconstructions
were kept completely separately, and the final resolution estimate (at the post-processing stage in
RELION) was based on the standard FSC between the two unfiltered half-reconstructions. Signal
subtraction of the micelle was performed as described in the results section and were used only in
the last iteration of refinement. Application of ‘particle polishing’ in RELION (corrects for beam
induced motion and performs experimental dose-weighting) did not improve the quality of the den-
sity. Local resolution was calculated with RELION.
Model building and refinement was carried out using the CCP-EM software suite (Burnley et al.,
2017). The activated A2AR and mini-GS coordinates were taken as starting models (PDB code 5g53)
together with the bg coordinated from the b2AR complex structure (Rasmussen et al., 2011). Jelly-
body refinement was performed in REFMAC5 (Murshudov et al., 2011) followed by manual modifi-
cation and real space refinement in Coot (Emsley and Cowtan, 2004). Refinement with restraints
(generated in ProSMART [Nicholls et al., 2012]) was performed in REFMAC5 in order to maintain
the secondary structure in regions with poorer map quality. Validation of the model was performed
in Coot, Molprobity (Chen et al., 2010) and EMRinger (Barad et al., 2015). The goodness of fit of
the model to the map was carried out using Phenix (Adams et al., 2010), using a global model-vs-
map FSC correlation (Figure 3).
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